Ceva Animal Health (Ceva), the world’s fifth-largest animal health company operating in 110 countries, is implementing strategic organizational changes across Asia Pacific (APAC) and China to accelerate growth and drive operational excellence.
As part of this strategic realignment, Ceva has relocated its Asia Pacific regional headquarters to Shanghai, positioning the company to serve the dynamic markets in the region more effectively.
Arnaud Leboulanger is appointed Senior Vice President (SVP) of the new APAC & China region.
Anh-Mai Vu, currently Director of Global E-Commerce, is appointed Head of Pet Products for the APAC & China region.
Their collective experience and commitment will help ensure a smooth transition and sustainably support Ceva’s development in the APAC and China regions.
Speaking on this leadership change, Andras Bolcskei, Executive Vice-President, Global Commercial Operations, said:
“Today’s appointment builds upon the solid foundations established by Arnaud. We sincerely appreciate his leadership and are confident it will continue to guide him successfully in his new role. His ability to deliver results across all species, from livestock to pets, will be a key asset as he steps into this expanded responsibility. We look forward to seeing him and his team drive accelerated growth across APAC and China.”
Commenting on his new appointment, Mr Leboulanger said:
“We are excited to begin this new chapter for Ceva in the Asia Pacific and China region. Relocating our regional headquarters to Shanghai reflects our commitment to being closer to our dynamic and rapidly evolving markets. With a strategic focus on innovation, operational excellence, and customer-centricity, we are well-positioned to accelerate growth and create sustainable value for our customers, partners, and the communities we serve. I look forward to leading our talented teams through this important transformation and unlocking the full potential of this vibrant region.”
About Ceva Animal Health
Ceva Animal Health (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being.
Its portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers.
With more than 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”.
2025 turnover: €1.92 billion
Visit www.ceva.com
Interview Dr. Nivin Nasser
Subscribe now to the poultry technical magazine
AUTHORS
Setting the Global Standard for Soy
Isa Tan
Importance of Eggshell Temperature, Checking and Record Keeping in a Commercial Poultry Hatchery
Rasel Ahmed
The Reality of the South African Egg Industry
Abongile Balarane
Mycoplasmosis update: Antimicrobial Resistance, Vaccines, and Control Challenges
Edgar O. Oviedo Rondón
Future Flock: Antibiotic-Free Solutions for a Rising Population
Dr Ahmad Safi Dr. Faran HameedInterview Dr. Nivin Nasser
Dr. Nivin Nasser
Disinfection of Fertile Broiler Breeder Eggs
Edgar O. Oviedo Rondón
Precision Matters: Tackling Quality Issues in on‑Farm Vaccination
Jaime Sarabia Fragoso Kevin Gandon Pascal Paulet
Process Control: 30 Specific Aspects to Evaluate from Pre-Slaughter to Slaughter
Eduardo Cervantes López
Ishikawa Diagram Applied to Processing of Chickens
Eduardo Cervantes López
